Skandinaviska Enskilda Banken Ab (Publ) Rocket Pharmaceuticals, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $19.9 Billion
- Q1 2025
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 22,967 shares of RCKT stock, worth $63,618. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,967
Previous 22,967
-0.0%
Holding current value
$63,618
Previous $288,000
46.88%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RCKT
# of Institutions
258Shares Held
108MCall Options Held
555KPut Options Held
177K-
Rtw Investments, LP New York, NY17.7MShares$49 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$35 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$18.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$17.2 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$14.4 Million0.68% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $210M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...